Clinical & Biochemical Correlates of Bradyphrenia in Parkinson's Disease
Neurol 37:1130-1134, Mayeux,R.,et al, 1987
The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP
NEJM 312:1418-1421, Burns,R.S.,et al, 1985
Memory Impairment in Korsakoff's Psychosis:A Correlation with Brain Noradrenergic Activity
Science 202:905-907, McEntee,W.J.,et al, 1978
Laboratory Diagnosis of Creutzfeldt-Jakob Disease
NEJM 386:1345-1350, Zerr, I., 2022
Sporadic Creutzfeldt-Jakob Disease in a Very Young Person
Neurol 97:813-816,801, Appleby, B.S.,et al, 2021
Rapid Progression of Prion Disease Associated with Transverse Myelitis
Neurol 94:e1670-e1672, Hussein, O.,et al, 2020
Dressing Apraxia as Initial Manifestation of Creutzfeldt-Jakob Disease
Tremor and Other Hyperkinetic Movements 10:1-3, Heckmann, J.G.,et al, 2020
Challenging Diagnosis of Gerstmann-Straussler-Scheinker Disease
Neurol 92:101-103, Kang, M.J.,et al, 2019
Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease
JAMA Neurol 75:65-71, Hamid, S.H.M.,et al, 2018
Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018
Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Positive Hypertrophic Pachymeningitis
Neurol 89:e253-e254, Culbertson, C.J.,et al, 2017
IGG4-Related Hypertrophic Pachymeningitis Coexpressing Antineutrophil Cytoplasmic Antibodies
Neurol 4:e341-e343, Massey, J., 2017
Human Neurexin-3a Antibodies Associate with Encephalitis and Alter Synapse Development
Neurol 86:2235-2242,2222, Gresa-Arribas, N.,et al, 2016
Neuromyelitis Optica Spectrum Disorders
UpToDate, May, Glisson,C.C., 2016
A 64-year-old Man with Visual Distortions
Neurol 87:e252-e256, McGrath, E.R.,et al, 2016
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Creutzfeldt-Jakob Disease (Subacute Spongiform Encephalopathy)
Adams & Victors Principles of Neurology, Chp 33, pg 769, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Intravascular Lymphoma
Adams & Victors Principles of Neurology, Chp 31, pg 663, Ropper, A.H.,et al, 2014
Clinicopathologic Conference, Cerebral Granulomatosis with Polyangiitis
NEJM 371:162-173, Case 21-2014, 2014
Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013
Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013
A Comparison of Tau and 14-3-3 Protein in the Diagosis of Creutzfeldt-Jakob Disease
Neurol 79:547-552, Hamlin, C.,et al, 2012
Evidence-based Guideline: Diagnostic accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease
Neurol 79:1499-1506, Muayqil, T.,et al, 2012
CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011
Treatable Neurological Disorders Misdiagnosed as Creutzfeldt-Jakob Disease
Ann Neurol 70:437-444, Chitravas, N.,et al, 2011
NMO-IgG Detected in CSF in Seronegative Neuromyelitis Optica
Neurol 72:1101-1003, Klawiter,E.C.,et al, 2009
Aicardi-Gouti�res Syndrome: Neuroradiologic Findings and Follow-up
AJNR 30:1971-1976, Uggetti,C.,et al, 2009
Isolated Cortical Signal Increase on MR Imaging as a Frequent Lesion Pattern in Sporadic Creutzfeldt-Jakob Disease
AJNR 29:1519-1524, Meissner,B.,et al., 2008
Clinicopath conf., Human Prion Disease, Sporadic CJD
Neurol 69:1881-1887, Geschwind,M.D., et al, 2007
Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007
Detection of CSF 14-3-3 Protein in Guillain-Barr Syndrome
Neurol 67:2211-2216, Bersano,A.,et al, 2006
CSF Tests in the Differential Diagnosis of Cretuzfeldt-Jakob Disease
Neurol 67:637-643, Sanchez-Juan,P.,et al, 2006
Carbamazepine Encephalopathy Masquerading as Creutzfeldt-Jakob Disease
Neurol 65:650-651, Horvath,J.,et al, 2005
Clinicopath Conf, Prion Disease (Sporadic Creutzfeldt-Jakob Disease)
NEJM 353:1042-1050, Case 27-2005, 2005
Diffusion-Weighted MRI Abnormalities as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease
Neurol 63:443-449,410, Shiga,Y.,et al, 2004
Sensitivity of 14-3-3 Protein Test Varies in Subtypes of Sporadic Creutzfeldt-Jakob Disease
Neurol 63:436-442,410, Castellani,R.J.,et al, 2004
CJD--A Case of Mistaken Identity
Lancet 364:2068, Campbell,S.,et al, 2004
14-3-3 Protein in the CSF of Patients with Rapidly Progressive Dementia
Neurol 61:354-357, Huang,N.,et al, 2003
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 60:813-816,803, Geschwind,M.D.,et al, 2003
Tau Protein and 14-3-3 Protein in the Differential Diagnosis of Creutzfeldt-Jakob Disease
Neurol 58:192-197, Otto,M.,et al, 2002
14-3-3 Protein Cerebrspinal Fluid Detection in Human Growth Hormone-Treated Creutzfeldt-Jakob Disease Patients
Ann Neurol 49:257-260, Brandel,J.,et al, 2001
CSF Detection of the 14-3-3 Protein in Unselected Patients with Dementia
Neurol 56:1528-1533, Burkhard,P.R.,et al, 2001
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Quantitation of 14-3-3 and Neurol-Specific Enolase Proteins in CSF in Creutzfeldt-Jakob Disease
Neurol 57:728-730, Aksamit,A.L.,et al, 2001
14-3-3 Protein in the CSF as Prognostic Marker in Early Multiple Sclerosis
Neurol 57:722-724, Martinez-Yelamos,A.,et al, 2001
Diagnosis of New Variant Creutzfeldt-Jakob Disease
Ann Neurol 47:575-582, Will,R.G.,et al, 2000
14-3-3 Testing in Diagnosing Creutzfeldt-Jakob Disease
Neurol 55:514-516, Lemstra,A.W. et al, 2000
Misleading Results With the 14-3-3 Assay for the Diagnosis of Creutzfeldt-Jakob Disease
Neurol 55:1396-1397, Chapman,T.,et al, 2000
Dementia with Lewy Bodies in a Neuropathologic Series of Suspected Creutzfeldt-Jakob Disease
Neurol 55:1401-1404, Haik,S.,et al, 2000